Clinical Trial Update: A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants [Phase 1, Phase 2]

View source ↗

Summary

A double-blind Phase 1/2 trial evaluated the safety of glutamic acid decarboxylase gene transfer in Parkinson's disease. The study has completed and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Glutamic Acid Decarboxylase gene transfer

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-09-05